SCHEMBL2158156

SCHEMBL2158156

NC(=O)c1c(Cl)c(-c2cccnc2)n2c1C(=O)C(Cl)(Cl)CC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 6/20 0.39
MKNK2 Q9HBH9 5/20 0.39
RET P07949 1/20 0.38
KCNH2 Q12809 1/20 0.38
CYP11B2 P19099 6/20 0.36
CSNK1D P48730 1/20 0.36
CSNK1E P49674 1/20 0.36
F2 P00734 1/20 0.35
F12 P00748 1/20 0.35
MAPT P10636 1/20 0.35
KLK7 P49862 1/20 0.35
KLK5 Q9Y337 1/20 0.35
P2RX7 Q99572 1/20 0.34
F7 P08709 1/20 0.34
F3 P13726 1/20 0.34
SARM1 Q6SZW1 1/20 0.34
SIRT2 Q8IXJ6 1/20 0.34
SIRT6 Q8N6T7 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
SIRT3 Q9NTG7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2343998 0.83 CYP11B2 (0.37) KCNH2CYP11B2MAPTP2RX7CYP1A2
SCHEMBL2344003 0.83 CYP11B1 (0.36) KCNH2CYP11B2MAPTP2RX7CYP1A2
SCHEMBL2157245 0.81 CYP11B2 (0.42) CYP11B2IKBKBCYP1A2CYP11B1
SCHEMBL2157432 0.80 CYP11B2 (0.44) MKNK1MKNK2KCNH2CYP11B2CSNK1D
SCHEMBL7591015 0.77 KCNH2 (0.41) MKNK1MKNK2KCNH2CYP11B2CSNK1D
SCHEMBL7946379 0.76 CYP11B2 (0.42) MKNK1MKNK2KCNH2CYP11B2CSNK1D
SCHEMBL895772 0.75 MKNK1 (0.41) MKNK1MKNK2KCNH2CYP11B2CSNK1D
SCHEMBL7953077 0.74 MKNK1 (0.40) MKNK1MKNK2RETKCNH2CYP11B2
SCHEMBL2158254 0.74 MKNK1 (0.43) MKNK1MKNK2RETKCNH2CYP11B2
SCHEMBL4040261 0.73 MKNK1 (0.42) MKNK1MKNK2KCNH2CYP11B2CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2361253-A1 COMPOUNDS Selcia Limited (GB) 2011-08-31 EP claimed
US-20110184011-A1 Compounds SELCIA LIMITED (GB) 2011-07-28 US claimed
WO-2010029364-A1 COMPOUNDS SELCIA LIMITED (GB) 2010-03-18 WO claimed
EP-2361253-A1 COMPOUNDS Selcia Limited (GB) 2011-08-31 EP disclosed
US-20110184011-A1 Compounds SELCIA LIMITED (GB) 2011-07-28 US disclosed
WO-2010029364-A1 COMPOUNDS SELCIA LIMITED (GB) 2010-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110184011-A1 Compounds COL1A1, ALDH1A2, COL2A1 MKNK1 3856/4885MKNK2 3481/4885RET 3307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.